risk assessment

(redirected from risk estimation)
Also found in: Dictionary, Encyclopedia.
Related to risk estimation: Risk assessment, risk evaluation

risk assessment

Social medicine
As refers to patient care in the UK, the evaluation of the risks to a person’s health based on his or her needs for living independently, weighed against the likely outcome for the individual, his or her carers or staff, and society, if assistance is not provided.

risk assessment

Managed care An activity that IDs risks and estimates their probability and the impact of their occurrence; RA is integral to system development as a means of estimating damage, loss, or harm that could result from a failure to develop individual system components. See Dose response assessment, Hazard identification, Risk characterization Toxicology The process by which new chemical substances are evaluated for their potential impact on human health, a process that entails determining its toxicity and number of people exposed to it. See Ames test, Morbidity, Toxicity testing.

risk as·sess·ment

(risk ă-ses'mĕnt)
Analysis of risks involved prior to action being taken.

risk assessment

A study of a patient, taking into account all known relevant factors, done for the purpose of trying to determine the probability that that person will develop a particular disease or, if the disease is already present, the probability that the person will suffer exacerbation of it or death from it.

risk as·sess·ment

(risk ă-ses'mĕnt)
Determination of possible future disease by identifying risk factors in comparison with possible protective factors.
References in periodicals archive ?
In the context of the Konin mining region, the process of risk estimation is supported by this work, but risk evaluation and management are the responsibility of the end-users, that is the Konin County Administration and the Mine Management.
It is convenient to estimate the level of risk with the use of risk estimation graph (Fig.
Risk estimation entails the assignment of probabilities to the events--responses--identified under risk identification.
There is, of course, still hope that this will occur, as the basic premise under which BBDR modeling was pursued for risk estimation is conceptually valid.
Risk analysis contains the following steps: scope definition, hazard identification, and risk estimation. The description of the system, scope and expectations of risk analysis should be defined at the outset.
In addition to the classical combination of transverse limb anomalies and ACC, other malformations such as cardio-vascular, pulmonary and orofacial defects have also been reported with AOS.2,3 Furthermore, there is a phenotypic overlap with other well-characterized malformations like Poland syndrome (OMIM 173800), cutis marmorata telangiectatica congenita (OMIM 219250), and aplasia cutis congenita (OMIM 107600), which make its diagnosis challenging and may compromise accurate genetic counseling and risk estimation.1 Hence, a thorough assessment of clinical presentation is warranted.
Contributions of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, Risk Genetics, Archiving, and Monograph (MORGAM) Biomarker Project.
Although implementation of BBDR models for low-dose risk estimation have been limited mainly to cancer modeled using a two-stage clonal expansion framework, these problems are expected to be present in all attempts at BBDR modeling.
The remaining 11 performance measures are as follows: physical activity counseling; smoking/tobacco use; smoking/tobacco cessation; weight / adiposity assessment; weight management; blood pressure management; blood pressure control; blood lipid measurement; blood lipid therapy and control; global risk estimation; and aspirin use.
The concepts of risk estimation as used by medical professions, insurance industries, and policy-making bodies in Europe and the US are outlined, and clinicians are offered simple and practical suggestions on how to use them.
"A reliable risk estimation of endometrial cancer could help us to optimize the timing of endometrial biopsy, or even allow us to refrain from further diagnostic procedures," Dr.
Two discrepancies in disease risk estimation were detected for this individual among the 3 DTC strategies: a decreased risk for atrial fibrillation was noted by only deCODEme, whereas a decreased risk for rheumatoid arthritis was reported only by Navigenics.

Full browser ?